T cell-derived lymphotoxin regulates liver regeneration

Area of Science:

• Hepatology
• Immunology
• Regenerative Medicine

Background:

• Liver regeneration is vital for recovery from hepatic injury.
• While innate immunity's role is known, the adaptive immune system's function in liver regeneration remains unclear.
• Investigating adaptive immunity's role using lymphocyte-deficient and lymphotoxin-deficient mouse models.

Purpose of the Study:

• To elucidate the role of the adaptive immune system in liver regeneration.
• To determine the specific contribution of T cells and lymphotoxin to this process.
• To explore therapeutic potential of targeting the lymphotoxin pathway.

Main Methods:

• Utilized a 70% partial hepatectomy model in mice.
• Assessed liver pathology, survival rates, hepatocyte DNA synthesis, and cytokine expression.
• Employed lymphocyte-deficient and conditional lymphotoxin-deficient mouse models, including splenocyte transfers and antibody treatments.

Main Results:

• T cell deficiency significantly impaired liver regeneration post-hepatectomy.
• T cell-derived lymphotoxin was identified as critical for liver regeneration, with its deficiency leading to increased liver damage and reduced DNA synthesis.
• Treatment with an agonistic antibody to lymphotoxin beta receptor improved liver regeneration in lymphocyte-deficient mice by reducing injury and enhancing hepatocyte proliferation and survival.

Conclusions:

• The adaptive immune system directly regulates liver regeneration through a T cell-lymphotoxin axis.
• Targeting the lymphotoxin beta receptor pathway shows promise as a novel therapeutic strategy for promoting liver regeneration.
• This study highlights a new mechanism for controlling liver repair and potential clinical applications.